This study is for adults 18 and older with advanced or metastatic solid tumors. The research checks the safety and effects of an investigational medication. The study lasts about 24 months. Participants may need to visit the study location multiple times for check-ups and tests.
**Key Points:**
- **Study Length:** Approximately 24 months.
- **Eligibility:** Adults with advanced solid tumors; specific health criteria apply.
- **Commitment:** Multiple visits may be required over 2 years.
Participants must have a life expectancy of at least 12 weeks and must not have major health issues like active autoimmune diseases or previous serious heart conditions. If you are interested, your doctor will help decide if this study is a good fit based on your health and medical history.
How understandable was the trial content above?
Hard to understand
Easy to understand